Learn More
Medchemexpress LLC Cklf1-c19 | 960358-79-6 | 99.8% | 2225.54 | 1 MG

Supplier: Medchemexpress LLC HYP39821MG
CKLF1-C19 is the C-terminal peptide of human chemokine-like factor 1 (CKLF1). It interacts with CCR4 and inhibits chemotaxis induced by both CKLF1 and CCL17. CKLF1-C19 has demonstrated the ability to suppress allergic lung inflammation by inhibiting chemotaxis mediated by CCR3 and CCR4.
- Induces chemotactic migration of human Th2 cells at concentrations of 200 ng/mL or 500 ng/mL for 30 minutes.
- Inhibits CCL11-induced chemotaxis of mouse eosinophils and human CCR3-transfected or mouse CCR3-transfected HEK293 cells at 100 ng/mL for 30 minutes.
- A single intraperitoneal dose (0.01-100 μg, 200 μL) administered 30 minutes before OVA induction significantly reduces airway hyperresponsiveness (AHR) in comparison to the ovalbumin (OVA) group treated with saline.
- A single subcutaneous dose (0.5 mg or 1 mg, 200 μL) decreases CCL11-mediated recruitment of eosinophils into the peritoneal cavity in a mouse model of asthma.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.